M.R. Meijerink
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM (NCT06630624) | M.R. Meijerink | 2024-07-10 |
| CT-guided Percutaneous Radionuclide Therapy With 32P Microparticles in Patients With Non-progressive Locally Advanced Pancreatic Cancer (NCT07595835) | M.R. Meijerink | 2023-06-04 |
Track M.R. Meijerink automatically
Every clearance here is in the API, with alerts when new ones post.